• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Lifesign

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Lifesignsee related information
Date Initiated by FirmJanuary 15, 2010
Date PostedMarch 12, 2010
Recall Status1 Terminated 3 on October 05, 2011
Recall NumberZ-1110-2010
Recall Event ID 54267
Product Classification Kit, screening, staphylococcus aureus - Product Code JWX
ProductLifesign Staph Latex Kits, 6 ml For In Vitro Diagnostic Use Catalog Number: 50051 Manufactured for Lifesign LLC , Somerset, NJ 08873 A rapid latex agglutination test to detect Protein A and/or clumping factor for Staph aureus from culture media.
Code Information Lot Number: 1009029 Expiration Date: 06-2012
Recalling Firm/
Manufacturer
NERL Diagnostics Corporation
12 Almeida St
East Providence RI 02914-1002
For Additional Information ContactTina L. Lombari
401-824-2046
Manufacturer Reason
for Recall
Unreactive Staph latex reagent
FDA Determined
Cause 2
Process control
ActionNERL Diagnostics notified distributors on January 15, 2010, by letter to advise of the recall and request they examine inventory, discontinue use of affected lot numbers and discard any remaining inventory. In addition, if product was further distributed, notify the customers of the product recall. If you have any questions, please telephone 1-401-824-2046.
Quantity in Commerce125 kits
DistributionNJ
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-